Multiple Myeloma Clinical Trials in Boston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Active, not recruiting
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +146 more
2021-10-14
Oct 14, 2021
N
Recruiting
  • Multiple Myeloma
  • PHE885
  • Chicago, Illinois
  • +3 more
2021-10-14
Oct 14, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
2021-10-14
Oct 14, 2021
A
Terminated
  • Multiple Myeloma
  • +6 more
  • AMG 397
  • +2 more
  • Birmingham, Alabama
  • +20 more
2021-10-08
Oct 8, 2021
C
Terminated
  • B Cell Lymphomas
  • +3 more
  • ACTR T Cell Product
  • Gilbert, Arizona
  • +15 more
2021-10-04
Oct 4, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +56 more
2021-10-07
Oct 7, 2021
A
Active, not recruiting
  • Multiple Myeloma
  • AMG 224
  • West Hollywood, California
  • +4 more
2021-09-09
Sep 9, 2021
P
Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +45 more
2021-10-06
Oct 6, 2021
G
Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
2021-09-30
Sep 30, 2021
O
Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +108 more
2021-09-27
Sep 27, 2021